Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

DSIT scorecard maps the funding barbell

3 min read
16:30UTC

DSIT's first sector scorecard sets a 2025 baseline of £8.3bn across 1,284 deals, against the $10.5bn Lowdown already counted in the first four months of 2026.

TechnologyDeveloping
Key takeaway

Britain pulled in far more tech capital than last year, spread across fewer deals piling into bigger, later companies.

DSIT published the Digital and Technologies Sector Plan Year One Update on 10 June, its first authoritative scorecard, counting 107,082 active tech companies generating £158bn in GVA (gross value added) and 655 active university spinouts⁠1. UK companies were granted 1,521 patents in 2024, 41% of the national total through the Intellectual Property Office.

The capital figures tell the sharper story. The scorecard logs £8.3bn of equity across 1,284 deals for the whole of 2025; Lowdown reported $10.5bn landing in the first four months of 2026 alone. Roughly the same money is now arriving in a third of the time, yet the deal count is falling. That is the barbell stated in the government's own data: more capital, fewer rounds, the middle hollowing out.

A founder raising a mid-sized Series A is competing for attention in the exact band that is thinning, while mega-rounds soak up the Headline capital. The same pattern showed in OQC closing £260m the same week the scorecard measures. The plan also surfaced fresh raises, including NuQuantum's $60m Series A, the largest quantum-networking round globally, Optalysys at £23m, and Cambridge GaN Devices closing a $32m Series C.

Deep Analysis

In plain English

The UK government department DSIT (Department for Science, Innovation and Technology) published its first annual progress report on the UK tech sector on 10 June 2026. It counted 107,082 active tech companies contributing £158bn to the UK economy, with investors putting £8.3bn into 1,284 deals in 2025. The report also named three funding rounds from the period: NuQuantum, a quantum networking company, raised $60m in the largest global round in its field; Optalysys, an optical computing company, raised £23m; and Cambridge GaN Devices, a semiconductor startup, closed a $32m round. The scorecard sets a baseline that DSIT will compare against each year to measure whether its industrial policy is working.

What could happen next?
  • Meaning

    DSIT's 2025 baseline of £8.3bn across 1,284 deals was already being outpaced by the January-April 2026 run-rate of $10.5bn (ID:2700), which will make the 2026 Year Two scorecard appear to show explosive growth regardless of policy effectiveness.

  • Risk

    The 655 active spinouts metric has no quality threshold: companies that have not traded, raised further capital or generated IP since formation are counted alongside commercially active ones, inflating the pipeline health signal.

First Reported In

Update #8 · London startup raises Britain's own AI model

DSIT· 14 Jun 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.